期刊文献+

血管内介入联合中药治疗中晚期肝癌临床疗效比较 被引量:1

Clinical efficacy study of TAI/TACE combined with traditional Chinese medicine in treating advanced hepatoma
下载PDF
导出
摘要 目的:比较血管内介入栓塞术(TAI/TACE)与联合中药治疗中晚期肝癌的临床效果。方法:将186例失去手术机会的中晚期肝癌患者,随机分成两组进行治疗,一组(A组)90例,行经导管动脉化疗栓塞术,另一组(B组)96例,在进行经导管动脉化疗栓塞术的同时,给予系统的中医药治疗,治疗全程对患者的生存率、生活质量进行半年、1、2、3、4、5年的随访。结果:两组患者术后半年、1、2、3、4、5年的生存率分别为92.5%、80.6%、48.3%、21.5%、8%、2.2%与96.8%、88.7%、67.2%、35.5%、15%、4.2%,B组生存率明显高于A组。生存期内,B组患者的生活质量明显好于A组患者。结论:血管内介入栓塞术与中医药治疗的联合应用,可明显延长患者的生存期与提高患者的生活质量。 Objective: To cvaluate the clinical efficacy of advanced hepatoma by comparing TAI/TACE with TAI/TACE combined with traditional Chinese medicine. Methods: One hundred and eighty-six cases of advanced hepatoma,who had lost opportunity of operation,were divided into two groups randomly: group A and group B. There were 90 cases in group A and 96 cases in group B,the cases of group A were treated with TA1/TACE,the cases of group B were treated witb TAI/TACE combined with traditional Chinese medicine meanwhile. All cases were followed-up in half, one, two. three, four, five years on exist rate and life qualily. Results: The exist rate of group A and group B in half. one, two, three, four, five years were 92.5%,80.6%,48.3%,21.5%.8%,2.2% and 96.8%,88. 7%,67. 2%,35. 5%,15%0,4. 2% respectively, the life quality of group B was obviously better than group A during existence. Conclusion: TAI/TACE combined with traditional Chinese medicine could obviously prolong the existence and improve the life quality.
出处 《中国中西医结合影像学杂志》 2005年第4期262-264,共3页 Chinese Imaging Journal of Integrated Traditional and Western Medicine
关键词 经动脉导管化疗 栓塞术(TAI/TACE) 中医药 中晚期肝瘤 TAI/TACE,Traditional Chinese medicine, Advanced hepatoma
  • 相关文献

参考文献4

二级参考文献50

共引文献63

同被引文献7

  • 1王克金 李生智 李明华等.肝癌肝动脉化疗栓塞治疗(附194例分析)[J].介入医学杂志,1999,4(1):37-37.
  • 2Ochiai T,Sonoyama T,Kikuchi S,et al.Intrahepatic arterial chemotherapy with 5-fluorouracil and intramuscular interferonalpha for a patient with diffuse type of hepatocellular carcinoma[J].Gan To Kagaku Ryoho,2004,31(11):1815-1818.
  • 3Noda T,Nagano H,Wada H,et al.The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma[J].Gan To Kagaku Ryoho,2006,33(9):1221-1225.
  • 4Arcement CM,Towbin RB,Meza MP,et al.Intrahepatic chemoembolization in unresectable pediatric liver malignancies[J].Pediatr Radiol,2000,30(11):779-785.
  • 5Gunji T,Kawauchi N,Akahane M,et al.Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma[J].Int J Oncol,2002,21(2):427-432.
  • 6Kokudo N,Makuuchi M.Current role of portal vein embolization/hepatic artery chemoembolization[J].Surg Clin North Am,2004,84(2):643-657.
  • 7周泽健,罗鹏飞,邵培坚,陈晓明,张良明,李伟科,李勇,许荣德,庄文行,张华.介入治疗后38例中晚期肝癌患者生存5年以上的因素分析[J].中华放射学杂志,2002,36(9):792-796. 被引量:29

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部